Based on 1 analyst offering 12 month price targets for Tiziana Life Sciences Ltd
Min Forecast
$7.00+621.65%
Avg Forecast
$7.00+621.65%
Max Forecast
$7.00+621.65%
Should I buy or sell TLSA stock?
Based on 1 analyst offering ratings for Tiziana Life Sciences Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TLSA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TLSA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More
Be the first to know when Wall Street analysts revise their TLSA stock forecasts and price targets.
Is Tiziana Life Sciences Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: TLSA) stock is to Strong Buy TLSA stock.
Out of 1 analyst, 1 (100%) are recommending TLSA as a Strong Buy, 0 (0%) are recommending TLSA as a Buy, 0 (0%) are recommending TLSA as a Hold, 0 (0%) are recommending TLSA as a Sell, and 0 (0%) are recommending TLSA as a Strong Sell.
What is TLSA's earnings growth forecast for 2026-2026?
(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Tiziana Life Sciences's earnings in 2026 is -$18,431,000.
In 2026, TLSA is forecast to generate -$19,666,808 in earnings, with the lowest earnings forecast at -$18,895,560 and the highest earnings forecast at -$20,245,243.
What is TLSA's revenue growth forecast for 2026-2026?
(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Tiziana Life Sciences's revenue in 2026 is $0.
In 2026, TLSA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is TLSA's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: TLSA) forecast ROA is -171.09%, which is lower than the forecast US Biotechnology industry average of -17.12%.
What is TLSA's Price Target?
According to 1 Wall Street analyst that have issued a 1 year TLSA price target, the average TLSA price target is $7.00, with the highest TLSA stock price forecast at $7.00 and the lowest TLSA stock price forecast at $7.00.
The Wall Street analyst predicted that Tiziana Life Sciences's share price could reach $7.00 by Sep 3, 2027. The average Tiziana Life Sciences stock price prediction forecasts a potential upside of 621.65% from the current TLSA share price of $0.97.
What is TLSA's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: TLSA) Tiziana Life Sciences's current Earnings Per Share (EPS) is -$0.16. In 2026, TLSA's EPS is forecast to hit -$0.16 (min: -$0.16, max: -$0.17).
What is TLSA's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: TLSA) forecast ROE is -37,820.78%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.